1Bz-LSD

Last updated

1Bz-LSD
1Bz-LSD.svg
Clinical data
Other names1-Benzoyl-LSD; SYN-L-018
Routes of
administration 		Oral [1]
Drug class Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Chemical and physical data
Formula C27H28N3O2
Molar mass 426.540 g·mol−1
3D model (JSmol)
  • CCN(CC)C(=O)[C]1CN(C)[C@@H]2Cc3cn(C(=O)c4ccccc4)c5cccc(C2=C1)c35
  • InChI=1S/C27H28N3O2/c1-4-29(5-2)26(31)20-14-22-21-12-9-13-23-25(21)19(15-24(22)28(3)16-20)17-30(23)27(32)18-10-7-6-8-11-18/h6-14,17,24H,4-5,15-16H2,1-3H3/t24-/m1/s1
  • Key:GVGINGNTVRBWSQ-XMMPIXPASA-N

1Bz-LSD, also known as 1-benzoyl-LSD or as SYN-L-018, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). [1] [2] It is thought to be a prodrug of LSD. [1] [2] The drug was patented by Lizard Labs in 2024. [2] Subsequently, it was encountered online as a novel designer drug in July 2024. [1] 1Bz-LSD has been sold in the form of blotter tabs and microdots containing 10 μg and 200 μg doses per unit. [1]

Contents

See also

References

  1. 1 2 3 4 5 "1Bz-LSD". AIPSIN (in Russian). Retrieved 1 January 2026.
  2. 1 2 3 WO 2024/028495,Stratford A, Williamson JP,"Prodrugs of Substituted Ergolines",published 8 February 2024, assigned to Synex Holdings BV
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.